Course in clinical studies including ICH- Good clinical practice (GCP901) is a very relevant course for PhD students doing clinical Research
At this course you will be given a thorough introduction to:

• ICH-GCP and laws relevant to clinical research including the Health Research Act and related regulations ICH-GCP
• on the design and conduct of clinical trials and development of some applications that are relevant to clinical research
• Different units inform what they can assist with in the implementation of clinical trials
• The importance of ethical considerations in clinical trialsThe PhD course GCP901 is a 1 ECTS course part of the Bergen Postgraduate School of Clinical Medical Research. It is led by Professor Eyvind Rødahl and Professor Thomas Halvorsen. NB! This is same course which was previously called “Good clinical practice (ICH-GCP) for PhD candidates”.

Dates:
Day 1: 26th of September (half day)
Day 2: 29^th of September (whole day)
Day 3: 7th of October (half day)

Registration: at the Studentweb by 1^st of September
If you have any questions regarding the course please feel free to contact:

Course content: Eyvind Rødahl – Eyvind.Rodahl@uib.no , Thomas Halvorsen-   thomas.halvorsen@helse-bergen.no or Stefan Johansson – Stefan.Johansson@uib.no Administrative matters: Solveig Lund Witsø Solveig.Witso@uib.no

Cytostatikaboken i ny utgave kan bestilles fra Bjørg Algerøy (bjorg.algeroy@helse-vest.no) tlf 72070.
Boken vil koste kr. 450,-

I forbindelse med vårt nye Illumina HiSeq4000 dyp-sekvenseringssystem vil Genomikk kjernefasiliteten invitere til NGS applikasjonsseminar torsdag 8 september.

Tid: 8 September, 13.00-16.00
Sted: Møterom 5.1/5.2 i 5 etg i Laboratoriebygget.

Vennligst se invitasjon her for mer informasjon og registrering til seminaret.

Vi har gleden av å invitere alle til neste K1/K2 seminar tirsdag 30.august.

Grant Brinkworth -PhD, associate professor, University of South Australia, Adelaide, Australia
Principal Research Scientist at CSIRO – Food and Nutrition, Adelaine, AUS
Long-term health and safety effects of Very Low Carbohydrate Diets for Type 2 Diabetes Management:
Current clinical practice guidelines for type 2 diabetes management advocate a diet low in fat and high in unrefined carbohydrates. However, this recommendation has been questioned following advancements in understanding that carbohydrate restriction and higher intakes of protein and unsaturated fat improve blood glucose control and cardiovascular disease risk.
This presentation will discuss the findings of a large, long-term, well-controlled, randomized controlled clinical study comparing the effects of either a traditional high-carbohydrate diet or a very-low-carbohydrate, high-unsaturated-fat diet while participating in a structured exercise program on multiple health outcomes, including glycemic control, cardiovascular disease risk, renal function, and mental wellbeing and performance.
Findings indicate that independent of any change in weight, the blood glucose profile improves substantially in the very-low-carbohydrate group. The diet is well tolerated and the need for medication is also reduced to a greater extent than the traditional high-carbohydrate dietary approach.
Tid: Tirsdag 30. August 14.30-15:30
Sted: Stort Auditorium, 3 etasje, Sentralblokken
Chair: Simon Dankel, Dep. Of Clinical Science, UiB

Pizza serveres fra 14:15-14.30.
Alle er velkomne!

Årets felles undervisningsdag for K1 og K2 holdes 12.Oktober 2016 på VilVite senteret.
Programmet for dagen finner du her. Trykk her for å melde deg på dagen.

I forbindelse med den årlige Scandinavian Conference in Cardiothoracic Surgery i Reykjavik 17.-19.august i år, var vår PhD-kandidat cand.med. Terje Aass nominert og vant prisen «C. Walton Lillehei, Ph.D., M. D. Young Investigators Award» på $5000 for sitt foredrag:

 Myocardial energy status and ultrastructure with polarizing and depolarizing             cardioplegic arrest in a porcine model. 

Terje Aass er overlege ved Thoraxkirurgisk seksjon, Hjerteavdelingen, Haukeland Universitetssykehus, og arbeider også med et doktorgradsprosjekt knyttet til Hjerteforskningsgruppen ved K2. Prosjektet er en dyreeksperimentell studie av en ny kardioplegiløsning som brukes for å stanse hjertet og beskytte myokard ved åpne hjerteoperasjoner der en bruker hjerte-lunge maskin.
Walton Lillehei, en amerikansk hjertekirurg med norske aner, betegnes internasjonalt som den åpne hjertekirurgiens far.

Det andre årlige Bergen Stem Cell Consortium (BSCC) møtet vil bli avholdt på Solstrand, 5 – 6 september 2016.
Klikk her for program

HELSEVEL-programmet lyser ut støtte til innovasjonsprosjekter i offentlig sektor med frist 12. oktober.
Målgruppen for utlysningen er aktørene i de offentlige helse-, omsorgs- og velferdstjenestene.

Vi presenterer Katarina Flaskerud, master i økonomi og administrasjon. Katarina begynte i august 2016 som økonomikonsulent ved K2. Hvis du ønsker å si hei, kan du finne henne i 8.etasje i laboratorietbygget.